M11.161 Familial chondrocalcinosis, right knee

Name of the Condition

• Familial chondrocalcinosis, right knee

Summary

Familial chondrocalcinosis, right knee is a hereditary condition characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the right knee joint and surrounding tissues. This leads to inflammation, pain, and potential joint damage. It is a subtype of calcium pyrophosphate deposition disease (CPPD) with a genetic basis, often presenting with recurrent joint symptoms. Diagnosis relies on clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, right knee is caused by genetic mutations that predispose individuals to abnormal calcium pyrophosphate crystal formation in the right knee’s cartilage, synovium, or periarticular structures. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Genetic predisposition (family history of CPPD or chondrocalcinosis).
• Advanced age (increased risk with aging, though familial cases may present earlier).
• Metabolic conditions affecting calcium or pyrophosphate levels (e.g., hemochromatosis, hyperparathyroidism).
• Right knee trauma or surgery.
• Certain medications (e.g., diuretics) that may alter crystal formation.

Symptoms

• Right knee pain, swelling, and stiffness.
• Recurrent episodes of acute inflammation.
• Limited range of motion in the right knee.
• Joint crepitus or grinding sensations.

Diagnosis

Diagnosis involves a thorough clinical evaluation, including a history of familial patterns and right knee symptoms. Imaging studies (e.g., X-rays, ultrasound) may show characteristic crystal deposits or joint changes. Joint fluid analysis to identify CPPD crystals is often confirmatory. Additional tests may rule out other conditions or assess metabolic factors.

Treatment Options

• Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation.
• Corticosteroid injections to reduce acute right knee swelling.
• Colchicine for recurrent flares.
• Physical therapy to maintain joint function and mobility.
• Management of underlying metabolic conditions if present.

Prognosis and Follow-Up

Prognosis depends on the extent of joint damage and response to treatment. Early intervention may slow progression, but chronic changes can lead to persistent symptoms. Regular follow-up with a healthcare provider is recommended to monitor joint function and adjust treatment as needed.

Complications

• Chronic right knee pain and stiffness.
• Progressive joint degeneration (osteoarthritis-like changes).
• Recurrent acute flares.
• Reduced mobility or disability if untreated.

Lifestyle & Prevention

• Maintain a healthy weight to reduce right knee stress.
• Avoid activities that strain the right knee.
• Follow prescribed treatment plans consistently.
• Monitor and manage metabolic conditions that may contribute to crystal formation.

When to Seek Professional Help

Seek care if right knee pain is severe, persistent, or worsening; if swelling or redness develops; or if mobility is significantly impaired. Acute flares with intense pain or fever also warrant prompt evaluation.

Tips for Medical Coders

Use this code for documented familial chondrocalcinosis specifically affecting the right knee. Ensure clinical documentation supports the hereditary nature and right knee involvement. Verify that the code aligns with the patient’s diagnosis and site specificity to avoid miscoding.